Labshake search
Citations for Bio X Cell :
1 - 50 of 654 citations for 6 4 Methyl 1 piperazinyl N 5 methyl 1H pyrazol 3 yl 2 1Z 2 phenylethenyl 4 pyrimidinamine since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2021Quote: ... plus 2 µg/mL anti-IL-4 antibody (BioXcell, Clone: 11B11); Th17 ...
-
bioRxiv - Microbiology 2021Quote: ... 10 μg·ml-1 anti-IL-4 and 10 μg·ml-1 anti-IL-2 (Bio X Cell, Cat# BE0043-1, RRID:AB_1107705). For Treg cell differentiation ...
-
bioRxiv - Cancer Biology 2024Quote: Antibody administration of anti-VLA-4 (clone PS/2, Bio X Cell #BE0071), anti-4-1BB (clone LOB12.3 ...
-
bioRxiv - Immunology 2019Quote: ... αIL-4 (5 μg mL−1, clone 11B11; Bio X Cell), rhTGF-β1 (2 ng mL−1 ...
-
bioRxiv - Cancer Biology 2020Quote: ... anti-IL-6 or anti-CTLA-4 antibodies (BioXCell). For CXCR3 blockade studies ...
-
bioRxiv - Immunology 2021Quote: ... 2 µg/mL anti-IL-4 and anti-IFNγ antibody (BioXcell, Clone: XMG 1.2). 10 µM SB525334 was used to replace TGF-β to inhibit TGF-β signaling if required ...
-
bioRxiv - Bioengineering 2023Quote: ... Mice in groups receiving αPD-1 and αCTLA-4 (100 µg, every 3 days for 5 injections, BioXcell, West Lebanon NH) were treated intraperitoneally ...
-
bioRxiv - Bioengineering 2023Quote: ... Mice in groups receiving αPD-1 and αCTLA-4 (100 µg, every 3 days for 4 injections, BioXcell, West Lebanon NH) were treated intraperitoneally ...
-
bioRxiv - Immunology 2019Quote: ... with 5 μg purified anti-mouse IL-2 antibody (JES6-1, BioXcell) for 30 min at 37°C (molar ratio for IL2:anti-IL-2 is 2:1) ...
-
bioRxiv - Immunology 2022Quote: ... cells were stained with anti-human ICAM-1-AlexaFluor647 (BioXcell, BE0020-2, 3 µM), anti-human CD58-AlexaFluor647 (BD Bioscience ...
-
bioRxiv - Cancer Biology 2023Quote: ... or isotype control antibody (200μg twice weekly for 2 weeks, a total of 4 times; clone LTF2, BioXcell).
-
bioRxiv - Cancer Biology 2021Quote: ... anti-4-1BB agonist (5 mg/kg, clone: 3H3, BioXcell), or anti-PD-1 (10 mg/kg ...
-
bioRxiv - Cancer Biology 2019Quote: ... an additional group (n=4) was injected with 250μg anti-CD25 antibody (PC-61.5.3, BioXCell). One saline group (n=5 ...
-
bioRxiv - Cancer Biology 2023Quote: ... injection of either a-PD-L1 antibody (200μg twice weekly for 2 weeks, a total of 4 times; clone 10F.9G2, BioXcell) or isotype control antibody (200μg twice weekly for 2 weeks ...
-
bioRxiv - Cancer Biology 2023Quote: ... anti-TIM3 Ab (4 μg/ml, clone RMT-3-23, BioXCell, Lebanon, NH), or 25-hydroxycholesterol (4 μM ...
-
bioRxiv - Immunology 2023Quote: ... injections every 3-4 days with 200 µg irrelevant antibody (clone 2A3, BioXCell), αPD-1 (clone RMP1-14 ...
-
bioRxiv - Immunology 2023Quote: ... or 4-1BB (5 µg/ml, clone 3H3, BE0239) all from BioXCell. Unless otherwise stated ...
-
bioRxiv - Cancer Biology 2024Quote: ... and/or 5 mg/kg anti-CTLA-4 (clone 9H10, cat. BE0131, BioXcell). Antibodies were dissolved in PBS and administered via intraperitoneal injection (4 μl/g ...
-
bioRxiv - Immunology 2021Quote: ... 1% GlutaMAX™ and 1% N-2-hydroxyethylpiperazine-N-2-ethane sulfonic acid [Gibco® HEPES]) and used as follow: TH1 conditions with anti–IL-4 (10 μg/mL, BioXCell, #BE0045) and IL-12 (10 ng/mL ...
-
bioRxiv - Immunology 2020Quote: ... human IgG1 Isotype control mAb (BioXcell, Labanon, NH; n=6), or PBS (n=5) ...
-
bioRxiv - Cancer Biology 2021Quote: Mice were treated with either IgG (5 mg/kg as an anti-4-1BB control, 10 mg/kg as an anti-PD-1 control, BioXcell), anti-4-1BB agonist (5 mg/kg ...
-
bioRxiv - Immunology 2022Quote: ... in the presence of 10μg/ml rIL-6 (R&D) and neutralizing antibodies to IL-2 (JES6-1A12 BioXcell, 5μg/ml and S4B6-1 BioXcell, 5μg/mL).
-
bioRxiv - Immunology 2022Quote: ... Cells were subsequently washed twice with PBS and incubated with anti-human ICAM-1-AlexaFluor647 (BioXcell, BE0020-2, 3 µM, 1:500 dilution) for 30 min at room temperature ...
-
bioRxiv - Immunology 2023Quote: ... 100 µg of CD4 and 100 µg of CD8 depleting antibodies were injected intraperitoneally in 100 µL sterile PBS per mouse 24 hours before challenge infection. 100 µg (Fig. 1) or 200 µg of the isotype control (Fig. 6) (clone LTF-2, Bio X Cell) were injected intraperitoneally in 100 µL of sterile PBS per mouse at the same time in control groups.
-
bioRxiv - Immunology 2022Quote: ... 5 ug/ml Brefeldin A was supplemented 4 hrs before subsequent Fc blocking (2.4G2, BioXCell), surface antibody staining ...
-
bioRxiv - Neuroscience 2023Quote: ... was mixed with anti-mouse IL-2 (5 μg; Bioxcell, Clone JES6-1A12) in PBS at 37 °C for 30 min ...
-
bioRxiv - Cancer Biology 2022Quote: ... or 3) respective isotype controls (HRPN and LTF-2; all InVivoMAb antibodies are from BioXCell). T-ALL burden was evaluated 24-48 hours after the final injection.
-
bioRxiv - Immunology 2021Quote: ... and anti-IL-4 (BioXCell); for Th2 ...
-
bioRxiv - Immunology 2023Quote: ... with anti-IL-2 (S4B6-1, BioXcell, 100 µg), anti-CD154 (MR1 ...
-
bioRxiv - Immunology 2023Quote: ... or Th17 – rhTGFβ (3 ng mL-1, Miltenyi) + rmIL-6 (20 ng mL-1, Miltenyi) + anti-IFNγ (10 μg mL-1, BioXcell). Cells were then transferred to uncoated tissue culture plates and cultured for an additional 3 days ...
-
bioRxiv - Immunology 2023Quote: ... and anti-CD28 (2 µg/ml, clone PV-1; BioXCell) or anti-NKG2D (10 µg/ml ...
-
bioRxiv - Immunology 2023Quote: ... They were differentiated (9) for 2 days with plate bound anti-CD3 and anti-CD28 (2 μg mL-1 each; BioXcell) into Th1 cells – 10 ng mL-1 rmIL-12 (R&D Biosystems ...
-
bioRxiv - Immunology 2020Quote: ... LFA blocking antibody (M17/4; BioXCell) was administered i.p ...
-
bioRxiv - Cancer Biology 2020Quote: ... and anti-CTLA-4 (BioXCell, BE0164) or isotype control (MSD IgG1 control for muDX400 ...
-
bioRxiv - Cancer Biology 2023Quote: ... and anti-CTLA-4 (BioXCell # BE0164) were diluted in PBS and dosed at 10 mg/kg every 3 days ...
-
bioRxiv - Immunology 2020Quote: ... 2 and 5 post infection with 200 μg of the depleting antibody YTS 169.4 (BioXCell). Depletion of CD8 T cells was determined to be ~90% on day 7 post infection in the BM.
-
bioRxiv - Cancer Biology 2021Quote: ... 250 μg PD-1 and CTLA-4 blocking (clone 9H10, BioXCell, Lebanon, NH) antibodies were injected intraperitoneally thrice per week for four weeks or a combination of PD-1 CTLA-4 antibodies with iBET762 were used.
-
bioRxiv - Immunology 2022Quote: ... or combination of PD-1 and CTLA-4 using anti-PD-1 (clone: RMP1-14, BioXcell), anti-CTLA-4 (clone ...
-
bioRxiv - Immunology 2023Quote: ... and anti-Ly-6C (clone: Monts 1, 2 mg/kg; BioXCell) were administered by intraperitoneal (i.p. ...
-
bioRxiv - Cancer Biology 2021Quote: ... IgG2b (LTF-2, Bioxcell), IgG1 (Bristol Myers Squibb) ...
-
bioRxiv - Immunology 2024Quote: ... and IL-4-reactive monoclonal antibodies for in vivo studies (IL-4 MAb) were purchased from BioXCell (BE0045). All TLR agonists were purchased from Invivogen ...
-
bioRxiv - Immunology 2020Quote: ... each of anti-LFA-1 and anti-VLA-4 blocking antibodies (Bio X Cell) or control IgG ...
-
bioRxiv - Immunology 2022Quote: ... in the presence of 10μg/ml rIL-6 (R&D) and neutralizing antibodies to IL-2 (JES6-1A12 BioXcell, 5μg/ml and S4B6-1 BioXcell, 5μg/mL).
-
bioRxiv - Immunology 2019Quote: ... anti-IL-4 (BioXcell, 11B11, 10ug/mL), IL-12 (Peprotech ...
-
bioRxiv - Cancer Biology 2021Quote: ... and anti-4-1BB (clone LOB12.3, BioXCell) treatment ...
-
bioRxiv - Immunology 2022Quote: ... and 3μg/mL anti–IL-4 (BioXcell) were used ...
-
bioRxiv - Immunology 2023Quote: Studies of anti-CTLA-4 (BE0032, BioXcell) therapy in mice bearing CT26 and B16 tumors ...
-
bioRxiv - Immunology 2023Quote: NK cells were depleted from C57BL/6 mice starting at 3-4 weeks of age by intraperitoneal injection of 200 µg of anti-NK1.1 mAb (clone PK136, Bio X Cell) every 5 days for 3 weeks.
-
bioRxiv - Immunology 2023Quote: ... Autocrine production of IL-2 was neutralized by the addition of an anti-IL2 antibody (InVivoMAb anti-mouse IL-2; clone JES6-1a12; BioXcell; Cat # BE0043-1) at 10 ng/ml ...
-
bioRxiv - Immunology 2022Quote: ... Inhibition of CTLA-4 signaling was performed by intraperitoneal injection of 500μg/dose of αCTLA-4 (clone: UC10-4F10-11, BioXcell) supplemented with 1mg/dose of IgG2b isotype (clone ...